[1] XINGMIAO CHEN. Pros and cons of current approaches for detecting peroxynitrite and their applications.[J]. Biomedical Journal, 2014, 37 3: 120-126. DOI:
10.4103/2319-4170.134084[2] BENJAMIN LAUZIER. A peroxynitrite decomposition catalyst: FeTPPS confers cardioprotection during reperfusion after cardioplegic arrest in a working isolated rat heart model[J]. Fundamental & Clinical Pharmacology, 2007, 21 2: 173-180. DOI:
10.1111/j.1472-8206.2007.00467.x[3] T P MISKO. Characterization of the cytoprotective action of peroxynitrite decomposition catalysts.[J]. The Journal of Biological Chemistry, 1998, 273 25: 15646-15653. DOI:
10.1074/jbc.273.25.15646[4] TAUHEED ISHRAT. Role of matrix metalloproteinase activity in the neurovascular protective effects of Angiotensin antagonism.[J]. Stroke Research and Treatment, 2014, 2014: 560491. DOI:
10.1155/2014/560491[5] JIANHUI LI. Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo.[J]. PLoS ONE, 2013: e70331. DOI:
10.1371/journal.pone.0070331[6] ATTILA KISS. The role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo.[J]. PLoS ONE, 2014: e104731. DOI:
10.1371/journal.pone.0104731